Christine Ann Fox serves as Executive at Mereo BioPharma Group plc, where they oversee executive responsibilities. Since joining the company, Christine Ann Fox has executed 6 insider transactions totaling $269.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 13, 2024 involved selling 19,158 shares valued at $80.8K.
Christine Ann Fox currently holds 89,285 shares of Mereo BioPharma Group plc (MREO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christine Ann Fox has been a net seller of MREO stock. They have purchased $0 and sold $269.4K worth of shares.
Christine Ann Fox's most recent insider trade was on Sep 13, 2024, when they sold 19,158 shares at $4.22 per share.
Get notified when new Form 4 filings are submitted
| $4.47 |
| Discretionary |
| Sep 11, 2024 | MREO | $0 | Option Exercise | 60,000 | $N/A | Discretionary |
| Jun 26, 2024 | MREO | $99.8K | Sale | 29,439 | $3.39 | Discretionary |
| Jun 25, 2024 | MREO | $47.9K | Sale | 12,990 | $3.69 | Discretionary |
| Jun 21, 2024 | MREO | $0 | Option Exercise | 90,000 | $N/A | Discretionary |